AI assistant
Korro Bio, Inc. — Director's Dealing 2023
Jul 13, 2023
33032_dirs_2023-07-12_ca159c9c-e257-4e4e-83a0-863f905878e8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: Frequency Therapeutics, Inc. (FREQ)
CIK: 0001703647
Period of Report: 2023-07-07
Reporting Person: Loose Christopher R. (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-07-07 | Common Stock | S | 1306 | $0.36 | Disposed | 203689 | Direct |
| 2023-07-10 | Common Stock | S | 1304 | $0.37 | Disposed | 202385 | Direct |
Footnotes
F1: Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person.
F2: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.34 to $0.36. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
F3: Includes 6,329 shares acquired under the Issuer's Employee Stock Purchase Plan on June 30, 2023.
F4: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.37 to $0.38. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.